Quick facts
- An activated partial thromboplastin time (APTT) test measures how long a plasma sample takes to clot after the intrinsic pathway is triggered — the test run to monitor heparin and to investigate a prolonged bleeding time.
- In the United States it files under 21 CFR 864.7925, Partial thromboplastin time tests, at Class II, with product codes GFO (activated partial thromboplastin), GGW (partial thromboplastin time test) and the reagent-and-control codes.
- In Canada it is an in vitro diagnostic device used for patient management and reaches Class II under Part 2 Rule 3 of Schedule 1.
- Rule 3 lifts an IVDD to Class III where it manages a life-threatening disease or an erroneous result would drive an imminent life-threatening decision; for the general APTT claim that lift is not engaged.
- The reagent is part of the device: a thromboplastin reagent with its control is described with the test it performs, not as a separate article.
- Entries, classes and product codes below were checked against the eCFR, the Regulations and the openFDA classification database on 2026-10-13.
The activated partial thromboplastin time is the clotting test that measures the intrinsic and common pathways of coagulation. A reagent activates the sample and supplies phospholipid without tissue factor; the time to clot is read on a coagulation analyser, and the result is used to monitor heparin therapy and to investigate an unexplained bleeding or a prolonged clotting time. In the United States it sits in a named regulation number at Class II; in Canada it is an in vitro diagnostic device that reaches the same class through the rules for patient management. This article sets out both routes and the records the result supports, with the graduated specimen cups that carry the plasma sample to the analyser.
What is an activated partial thromboplastin time test?
It is a one-stage clotting time. A citrated plasma sample is warmed and mixed with a reagent that contains a particulate activator and phospholipid, and calcium is added to start the reaction. The analyser records the seconds until a clot forms. Because the reagent supplies phospholipid but no tissue factor, the test reflects the intrinsic and common pathways — the part of the cascade that the extrinsic-prothrombin test does not read.
The result is reported in seconds and, for heparin monitoring, as a ratio against a normal control or as a patient-specific therapeutic range. The reagent's phospholipid composition is what makes the test sensitive or insensitive to a given heparin, so the reagent and the instrument are matched by the laboratory rather than mixed freely.
What class is an APTT test in the United States?
It is Class II. 21 CFR 864.7925 is titled Partial thromboplastin time tests and the entry sits at Class II. The openFDA device classification API lists product codes GFO (Activated Partial Thromboplastin), GGW (Test, Time, Partial Thromboplastin), GIT (Reagent & Control, Partial Thromboplastin Time) and GGO (Reagent, Thromboplastin And Control) under that regulation number. A Class II device of this kind reaches the market through the premarket notification route with the controls the regulation sets.
The regulation is written around the test, and the reagent is part of it. A reagent pack with its control and a ready-to-use cartridge that performs the same clotting time are described by the same device family, because the class attaches to the measurement and to what it is used for.
| Item | Detail |
|---|---|
| US regulation | 21 CFR 864.7925 - Partial thromboplastin time tests |
| US class | Class II |
| Product codes | GFO (activated partial thromboplastin), GGW (test, time, partial thromboplastin), GIT and GGO (reagent and control) |
| Route to market | Premarket notification before commercial distribution |
| Sample | Citrated plasma from a venepuncture specimen |
How does Canada classify an APTT test?
Canada treats it as an in vitro diagnostic device and reads Part 2 of Schedule 1 of the Medical Devices Regulations. The governing rule is Rule 3: "An IVDD that is intended to be used for patient management is classified as Class II, unless it falls into one of the following categories, in which case it is classified as Class III: (a) it is intended to be used for the management of patients suffering from a life-threatening disease; or (b) there is a risk that an erroneous result will lead to a patient management decision resulting in an imminent life-threatening situation for the patient." An APTT test used to monitor anticoagulation and to investigate a prolonged clotting time is an IVDD for patient management, so the Class II default of Rule 3 applies.
The lift to Class III is worth stating precisely because it is what a reader will look for. It is engaged where the intended use on the labelling ties the device to the management of a life-threatening disease, or where an erroneous result would lead to an imminent life-threatening decision. A general APTT assay carries the general patient-management claim, so the default holds and the class is Class II. Where the same analyser runs an assay whose claim does reach Rule 3(a) or (b), that assay's class is set by its own claim — and under Part 2 Rule 7, an analyser intended to be used with that IVDD follows the higher class of the pair.
| Item | Canada | United States |
|---|---|---|
| Named entry | None; classified by rule (IVDD, Part 2) | 864.7925, Class II |
| Class | Class II (Part 2 Rule 3) | Class II |
| Governing text | Schedule 1, Part 2, Rule 3 (with Rule 7 for pairs) | 21 CFR 864.7925 |
| Route to market | Device licence (Class II) with ISO 13485 evidence | Premarket notification |
| Would Rule 3(a)/(b) apply? | Only where the intended use ties the assay to a life-threatening disease | Handled inside the Class II entry |
How does this differ from the prothrombin time test?
The two clotting tests are ordered together and are often run on the same analyser, but they read different parts of the cascade and are described separately. The prothrombin time is triggered with tissue factor and reads the extrinsic and common pathways; the activated partial thromboplastin time supplies phospholipid without tissue factor and reads the intrinsic and common pathways. A laboratory keeps the two as separate assay lines with separate reagent packs and separate control records.
| Test | Trigger | Pathway read | Typical use |
|---|---|---|---|
| Prothrombin time | Tissue factor | Extrinsic and common | Warfarin monitoring |
| Activated partial thromboplastin time | Activator plus phospholipid | Intrinsic and common | Heparin monitoring; bleeding work-up |
| Thrombin time | Thrombin added directly | Fibrin formation | Heparin and fibrinogen interference |
The practical consequence for a purchaser is the same in both countries. A reagent chosen for one test is not a substitute for the other, and the intended use on the labelling is what fixes both the approved claim and the Canadian class. A laboratory that wants to run both on one analyser should reconcile the two assay lines separately rather than treat them as a single coagulation item.
What should a laboratory check before ordering one?
Three checks. First, confirm the exact regulation number, the product code and the intended use on the supplier's labelling, because the class attaches to the claim the assay carries. Second, confirm that the reagent and the analyser are matched for the heparin sensitivity the laboratory needs, since a reagent chosen for one indication is not a substitute for another. Third, confirm the lot-and-control trace the laboratory will keep, because a coagulation result is followed through the quality system rather than by a single value.
A coagulation laboratory also reorders the pre-analytical bench consumables that move with the same citrated specimen. The wider laboratory consumables range is listed under diagnostic laboratories. Clinics that stock for a whole practice can order through the wholesale programme and request a bulk quote for a standing or annual order; the graduated specimen cups sits in the same catalogue. Reselling? become a distributor.
How does the class affect a laboratory's routine?
The class sets the licence path; the laboratory's quality system sets the routine. An APTT result is recorded with the specimen, the reagent lot, the analyser and the control values for the run, so a result can be traced back to the run that produced it and compared with the laboratory's own reference interval. The lot and control records are the ordinary evidence a laboratory keeps under its quality system, where ISO 15189 sits.
Because an APTT result can inform an urgent decision about bleeding or anticoagulation, the laboratory also applies its critical-result pathway and records who was called and when. None of that changes with the class; it is the ordinary routine a clinical laboratory keeps, and the record is what shows it was followed.
Sources
- openFDA device classification API
- Medical Devices Regulations, SOR/98-282, full text and Schedule 1
- Clinical and Laboratory Standards Institute
- Public Health Ontario, infection prevention and control
- ISO 15189:2022, medical laboratories, requirements for quality and competence
- World Health Organization
- US FDA, medical device databases
- US FDA, overview of device regulation
- Health Canada, medical devices
- Health Canada, establishment licensing
- Standards Council of Canada
- CSA Group
- ISO 13485:2016, medical devices quality management
- ISO 14971:2019, application of risk management to medical devices
- CCOHS, OSH answers
- Clinical and Laboratory Standards Institute, coagulation testing resources
- Health Canada, medical device licence application guidance
Printable record sheet. A coagulation laboratory keeps a printed evidence copy of its run records, and a printable sheet is the copy that goes into the quality file. Open the sterilization log sheet library — the downloadable pack holds a steam-cycle log, a reprocessing-room checklist and an equipment-maintenance sheet. No account and no sign-up; print as many copies as your log needs.
Log generator. Set the laboratory name, the analyser and the assay once and the generator lays out a dated run sheet for the month. Run the sterilization log generator to build a dated, facility-labelled cycle sheet you can print or file straight into your quality manual.
Ask a compliance specialist. Classification questions about a clotting assay usually turn on the intended use; a written answer keyed to your assay and province settles it. Ask a compliance specialist — you get a written answer specific to your equipment and province, with the regulation or standard it is based on cited.
Related reading
- Coagulation analysers in Canada vs the US
- Cardiac troponin tests in Canada vs the US
- Blood gas analysers in Canada vs the US
CliniEco Medical supplies eye care, laboratory and dental consumables of the kind described in this article. MDEL #35334. This article is written for optometry, laboratory and dental procurement professionals and is not legal advice; the class of a device and the records a practice keeps belong to the manufacturer and to the requirements that apply to it.
Frequently Asked Questions
What class is an activated partial thromboplastin time test in the United States?
Class II, under 21 CFR 864.7925, Partial thromboplastin time tests, with product codes GFO, GGW, GIT and GGO.
What class is it in Canada?
Class II, as an in vitro diagnostic device used for patient management under Part 2 Rule 3 of Schedule 1 of the Medical Devices Regulations.
Do the two countries agree?
Yes, both answer Class II, but for different reasons: the United States names the test in a Class II regulation, while Canada applies the general rule for IVDDs used in patient management.
When would the Canadian class rise to III?
Where the intended use on the labelling ties the assay to the management of a life-threatening disease, or where an erroneous result would lead to an imminent life-threatening decision, Rule 3 lifts the class to III.
Is the reagent a separate device from the test?
No. The thromboplastin reagent and its control are described with the test they perform, and the reagent-and-control product codes sit under the same regulation number.
What else is the APTT test called?
It is also written as APTT, activated PTT, partial thromboplastin time with activator, and aPTT; the plain partial thromboplastin time test shares the same regulation number.